THE DILI EXPERT JOURNAL-- A Drug-Induced Liver Injury Newsletter by Melissa Pallmer, MD --  Also Featuring Developments in  All Areas of Liver Disease

The DILI Expert Journal is Now Live!  

Medical Monitoring for Liver Drug Trial Safety

Medical monitoring is essential to trial safety, yet the role remains inconsistently defined across the industry. A recent LinkedIn poll of clinical research professionals showed strong support for creating a formal certification framework. With trial complexity rising, the conversation about medical monitoring is becoming increasingly important.
Below is a brief article summarizing the poll results and outlining what a practical, risk‑based framework could look like.
To discuss medical monitoring standards, reach out at info@medsurgpi.com.
Many thanks to all those who worked on this article: Roger Morgan, MD FACS; Melissa Palmer, M.D.; Freddy Byrth; Patrick F. Loebs, MSW, MPH, CPC; Emilia J.; Katie-Louise Dawson MD MPH